Cell Counting Kit-8 (CCK-8) |
Catalog No.GK10001 |
Cell Counting Kit-8 (CCK-8) is a ready-to-use one-bottle solution which offers a simple, rapid, reliable and sensitive measurement of cell viability and cytotoxicity of various chemicals.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2024):2401538.PMID:38738793
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Nat Commun 15.1 (2024):72.PMID:38167723
- Matter (2025).
- Nat Commun 15.1 (2024):3771.PMID:38704377
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- ACS nano (2025).PMID:39846120
- Acs Nano (2024).PMID:39361472
- Cancer Commun (2024).PMID:38512764
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Adv Sci (2023):2301107.PMID:37097746
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Autophagy just-accepted (2024).PMID:39007910
- Adv Sci (2024):2401845.PMID:38757623
- Brain Behav Immun (2024).PMID:38565398
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2024):2404365.PMID:39159143
- Microbiome 12.1 (2024):152.PMID:39152482
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Small (2024):2407674.PMID:39363789
- J Adv Res (2023).PMID:36933884
- Nano Today 61 (2025):102560.
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Water Res (2024):121379.PMID:38422694
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- Small Methods (2024):2400223.PMID:38602202
- Theranostics 12.7 (2022):3488.PMID:35547749
- Theranostics 14.16 (2024):6161.PMID:39431016
- Mater Horiz (2024).PMID:39189308
- Mater Horiz (2024).PMID:39189308
- Mol Ther (2025).PMID:39810420
- J Hazard Mater (2024):135904.PMID:39303616
- J Control Release 365 (2024):301-316.PMID:38007195
- Redox Biol 62 (2023):102663.PMID:36924682
- EBioMedicine 99 (2024).PMID:38101299
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- Redox Biol (2023):102983.PMID:38064762
- J Control Release 360 (2023):647-659.PMID:37406817
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- Acta Biomater 157 (2023):321-336.PMID:36481504
- Environ Sci Technol (2024).PMID:39364562
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Cell Discov 6.1 (2020):96.PMID:33349633
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- J Control Release 373 (2024):749-765.PMID:39084465
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Water Res (2024):122403.PMID:39278116
- Sci Total Environ 878 (2023):162942.PMID:36940749
- J Control Release 379 (2025):89-104.PMID:39756690
- J Control Release 359 (2023):12-25.PMID:37244298
- J Adv Res (2025).
- J Control Release 349 (2022):254-268.PMID:35803328
- Cancer Lett (2024):216765.PMID:38408604
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- Acta Biomater (2024).PMID:38452962
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Adv Healthc Mater (2024):2401061.PMID:38849128
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- Environ Pollut 334 (2023):122148.PMID:37419204
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Biomark Res 11.1 (2023):3PMID:36611218
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Acs Appl Mater Inter (2024).PMID:38345297
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- J Colloid Interf Sci (2025):.PMID:39755016
- Front Immunol 14 (2023):1130308.PMID:37006248
- Food Chem (2024):139505.PMID:38703732
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Cancer Lett 611 (2025):217418.PMID:39725146
- Brit J Cancer (2024):1-9.PMID:38594370
- Pharmacol Res (2024):107460.PMID:39393436
- Cancer Lett (2024):217418.PMID:39725146
- Acs Appl Mater Inter 15.32 (2023):38294-38308.PMID:37542453
- Acta Biomater (2025).PMID:39952883
- Environ Pollut 338 (2023):122581.PMID:37748638
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Acs Appl Mater Inter (2024).PMID:39448903
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Mater Today Bio (2024):101019.PMID:38516170
- Oncogene (2023):1-13.PMID:37138031
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Int J Biol Macromol (2025):140602.PMID:39922352
- Int J Biol Macromol (2024):133667.PMID:38969038
- Acs Sensors (2024).PMID:38958530
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Int J Biol Macromol (2024):131928.PMID:38688339
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Phytomedicine 118 (2023):154944.PMID:37393830
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Antivir Res 205 (2022):105381.PMID:35835291
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol (2025):140374.PMID:39880265
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol (2024):135979.PMID:39332550
- Acs Appl Mater Inter (2024).PMID:39320506
- Acs Appl Mater Inter (2025).PMID:39853325
- Environ Res (2024):118221.PMID:38246300
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Int J Biol Macromol (2024):135562.PMID:39276884
- Phytomedicine (2023):155270.PMID:38096717
- Sci China Life Sci (2025):1-11.PMID:39821161
- Int J Biol Macromol (2024):129172.PMID:38176496
- Int J Biol Macromol (2025):140632.PMID:39909240
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Sci 21.4 (2025):1837-1851.
- Int J Biol Macromol (2024):137561.PMID:39537068
- Int J Biol Macromol(2023):125130.PMID:37263336
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- J Gastroenterol (2023):1-14.PMID:37150773
- Front Nutr 9 (2022):812623.PMID:35419394
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Virol Sin (2023).PMID:37331658
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Brit J Pharmacol (2024).PMID:38715438
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Front Immunol 14 (2023):1111494.PMID:36817451
- J Med Chem (2024).PMID:38315032
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Life Sci 308 (2022):120925.PMID:36057399
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Front Immunol 14 (2023).PMID:37662906
- Life Sci 312 (2023):121092.PMID:36279968
- Free Radical Bio Med (2024).PMID:38367927
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Front Immunol 13 (2022):986214.PMID:36341437
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Front Immunol 13 (2022):902515.PMID:35874682
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Fertil Steril (2023).PMID:37178109
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Phytother Res (2024).PMID:38558449
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Phytomedicine (2024):155859.PMID:38972239
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- J Med Chem (2024).PMID:39292661
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- J Med Chem (2025).PMID:39842821
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Int J Nanomed 20 (2025):293-308.
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Phytomedicine 130 (2024):155744.PMID:38763011
- Food Res Int (2025):115940.
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Oncogene (2025):1-15.PMID:39920289
- Phytomedicine (2025):156515.PMID:39983438
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Biochem Pharmacol (2024):116044.PMID:38336157
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Exp Neurol 359 (2023):114266.PMID:36336032
- J Mater Chem B (2024).PMID:39119756
- Int J Mol Med 55.3 (2025):1-17.
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Biochem Pharmacol (2023):115632.PMID:37263300
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Resp Res 24.1 (2023):216.PMID:37674165
- Jci insight 9.15 (2024):PMID:38935435
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Cells 11.23 (2022):3816.PMID:36497076
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Life Sci (2024):122483.PMID:38307238
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Pharmacol 12 (2021):610158.PMID:33762939
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Mbio (2023):e01688-23.PMID:37882780
- Front Oncol 13 (2023):1132424.PMID:37251940
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Biomater Adv (2024):214069.PMID:39447240
- Front Oncol 13 (2023):1120103.PMID:36959804
- Phytother Res (2023).PMID:37086359
- Phytother Res (2023).PMID:37246830
- Front Pharmacol 11 (2020):16.PMID:32140106
- J Agr Food Chem (2023).PMID:37922022
- Front Immunol 15 (2024):1375781.PMID:39391314
- J Invest Dermatol (2025).PMID:39892773
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Front Immunol 15 (2024):1455996.PMID:39376562
- J Transl Med 23.1 (2025):131.PMID:39885513
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Microbiol Res (2024):127927.PMID:39393129
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Mol Med 30.1 (2024):14.PMID:38254010
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Front Immunol 15 (2024):1375781.PMID:39391314
- Front Immunol 15 (2024):1455996.PMID:39376562
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- J Nutr Biochem (2024):109678.PMID:38844080
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Talanta (2025):127591.PMID:39847915
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Apoptosis (2024):1-19.PMID:39097858
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Front Oncol 12 (2022):770628.PMID:35372056
- Front Oncol 12 (2022):858598.PMID:35321435
- Lab Chip (2024).PMID:38939907
- Jci Insight (2024). PMID:38935435
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Cells 11.24 (2022):4094.PMID:36552856
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Cns Neurosci Ther (2023).PMID:37452510
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Acs Biomater Sci Eng (2024).PMID:38445959
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Acs Biomater Sci Eng (2024).PMID:38446137
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Am J Chinese Med (2024):1-23.PMID:38490807
- Front Oncol 12 (2022):858598.PMID:35321435
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Int J Pharmaceut (2023):123142.PMID:37328119
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Mol Med 30 (2024):260.PMID:39707194
- Radiother Oncol (2024):110686.PMID:39709027
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Molecules 28.6 (2023):2426.PMID:36985397
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- J Oncol 2022 (2022).PMID:36213838
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Front Oncol 12 (2022):996080.PMID:36483054
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- J Oncol 2022 (2022):6459029PMID:36199788
- Cell Signal 113 (2024):110962.PMID:37931691
- Commun Biol 8.1 (2025):71.PMID:39820362
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- J Ethnopharmacol (2024):119272.PMID:39716512
- Molecules 27.21 (2022):7183.PMID:36364008
- Transl Oncol 52 (2025):102256.PMID:39733744
- J-Ethnopharmacol (2023):116729.PMID:37277081
- J Agr Food Res (2025):101694.
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Microorganisms 11.5 (2023):1268.PMID:37317242
- Front Oncol 12 (2022):1043161.PMID:36439418
- Front Endocrinol 13 (2022):657802.PMID:36263320
- J Ethnopharmacol (2024):119073.PMID:39522846
- J Dent (2024):105436.PMID:39488296
- Colloid Surface B (2025):114537.PMID:39879672
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- J Dent (2024):105436.PMID:39488296
- Mol Carcinogen (2023).PMID:37750597
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Toxicology (2024):154018.PMID:39608440
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- J Oncol 2022 (2022).PMID:36281290
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Biochem Pharmacol (2024):116688.PMID:39617210
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Molecules 27.14 (2022):4603.PMID:35889477
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- J Ethnopharmacol (2023):116731.PMID:37277084
- Glia (2024).PMID:39610064
- J Drug Deliv Sci Tec 104 (2025) 106577.
- Front Oncol 12 (2022):961653.PMID:36457504
- Molecules 27.17 (2022):5698.PMID:36080465
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- J Virol (2023):e00549-23.PMID:37222617
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- Molecules 27.23 (2022):8568.PMID:36500666
- Cell Signal (2023):110987.PMID:38029946
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Life Sci (2024):123148.PMID:39447733
- Acs Biomater Sci Eng (2024).PMID:39164198
- J Ethnopharmacol (2024):118080.PMID:38521426
- Mol Neurobiol (2024):1-18.PMID:38995443
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Biochem Pharmacol (2024):116438.PMID:39025409
- J Ethnopharmacol (2024):118685.PMID:39127116
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Clin Immunol (2024):110308.PMID:39002794
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- J Ethnopharmacol (2024):117985.PMID:38417600
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- J Ethnopharmacol (2024):117958.PMID:38395179
- J Oncol 2022 (2022).PMID:36213831
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Arch Toxicol (2024):1-16.PMID:38971901
- J Ethnopharmacol (2024):117865.PMID:38369066
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Macromol Biosci (2024):2400003.PMID:38597147
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Am J Physiol-Gastr L (2024).PMID:38742280
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Environ Toxico (2024).PMID:38700384
- Transl Oncol 47 (2024):102042.PMID:38924847
- Acs Appl Bio Mater (2024).PMID:38700956
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Macromol Biosci (2024):2400003.PMID:38597147
- Faseb J 38.7 (2024):e23591.PMID:38572579
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- J oncol 2022 (2022).PMID:36385962
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Bioengineering 9.9 (2022):433.PMID:36134979
- Environ Toxicol (2023).PMID:38069587
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- J Nutr Biochem (2024):109780.PMID:39395694
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Life Sci 254 (2020):117793.PMID:32416164
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- Environ Toxicol (2024).PMID:39400944
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Toxicol Sci (2024):kfae054.PMID:38636494
- Zool Res 45.5 (2024).PMID:39147715
- Brain Res Bull (2024):111165.PMID:39667505
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Heliyon (2024).PMID:38707472
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Pediatr Res (2024):1-10.PMID:38658662
- Endocrine (2024):1-14.PMID:38378893
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Gene (2023):148050.PMID:38042211
- J Inflamm Res (2024):10533-10546.PMID:39659750
- J Immunother (2024):10-1097.PMID:38847148
- J Cancer 15.5 (2024):1397.PMID:38356722
- Bmc Complement Med 24 (2024).PMID:38783288
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Front Oncol 14 (2024):1440906.PMID:39346724
- Zool Res 45.5 (2024):1001.PMID:39147715
- Acta Derm-Venereol 104 (2024).PMID:38590175
- J Inflamm Res (2024):8009-8026.PMID:39507268
- J Biol Chem (2024):107499.PMID:38944125
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Eur J Pharmacol (2024):176995.PMID:39277096
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- J Steroid Biochem (2023):106429.PMID:38035949
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Cytokine 176 (2024):156507.PMID:38244240
- Endocrine (2024).PMID:38191984
- Front Oncol 14 (2024):1471109.PMID:39582546
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Gerontology (2024).PMID:38168028
- Oral Dis (2024).PMID:38168877
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Gene (2024):148399.PMID:38518902
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Metabolomics 20.5 (2024):112.PMID:39369160
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Environ Toxicol (2023).PMID:37052456
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Neurochem Res (2023):PMID:37127800
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Eur J Pharmacol (2025):177343.PMID:39900330
- Neuroscience (2023).PMID:37286157
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Molecules 30.3 (2025):549.PMID:39942654
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- J Oncol 2022 (2022).PMID:35518787
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Ann Transl Med 10.24 (2022).PMID:36660714
- J Cancer 11.5 (2020):1162.PMID:31956362
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Brain Res Bull (2025):111245.PMID:39924054
- Heliyon 8.11 (2022).PMID:36353164
- J Neuro Oncol (2023):1-16.PMID:37351767
- Sci Rep-Uk 15.1 (2025):794.
- Front Genet 13 (2022):959109.PMID:36147489
- Front Genet 13 (2022):932973.PMID:36118847
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Virus Res 313 (2022):198748.PMID:35304133
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Future Microbiol 0 (2024).PMID:38629914
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- J Sci Food Agr (2024).PMID:39394871
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Dis Markers 2022 (2022).PMID:35845132
- Cell Transplant 33 (2024).PMID:38334047
- Dis Markers 2022 (2022).PMID:35968506
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- S Afr J Bot 177 (2025):445-456.
- Luminescence 39.1 (2024):e4671.PMID:38286599
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Tissue Cell 80 (2023):102001.PMID:36565506
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- J Mol Histol (2024):1-8.PMID:38758519
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- Shock 59.3 (2023):426-433.PMID:36609531
- Gene 932 (2025):148898.PMID:39209182
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Mol Biotechnol (2024):1-15.PMID:38771419
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Biomarkers (2024):1-12.PMID:38568742
- Heliyon (2024):.PMID:37461802
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Dis Markers 2022 (2022).PMID:35845132
- Technol Cancer Res T 19 (2020).PMID:33111613
- Oncol Res 32.6 (2024):1129.PMID:38827325
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Pathogens 14.2 (2025):182.
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Tissue Cell (2024):102477.PMID:39018712
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Genomics (2025):111009.PMID:39864635
- Luminescence 40.2 (2025):e70116.PMID:39914999
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Shock (2023):10-1097.PMID:37988072
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Shock (2023):10-1097.PMID:37179246
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Pathogens 14.2 (2025):182.
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Clinics 77 (2022).PMID:35662010
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- Mol Med Rep 31.3 (2025):1-10.
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Microb Pathogenesis (2024):107055.PMID:39442820
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Neuroreport 33.10 (2022):413.PMID:35623086
- Immunobiology (2024):152832.PMID:38943814
- Oncol Res 33.1 (2024):103.PMID:39735676
- J Int Med Res 48.4 (2020).PMID:31891283
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Cell J 24.1 (2022):15.PMID:35182060
- J Int Med Res 49.3 (2021).PMID:33730930
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Hematology 28.1 (2023):2220522.PMID:37272581
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Chin J Integr Med (2024):1-11.PMID:38941045
- Cell J 24.1 (2022):15.PMID:35182060
- Genes Genom (2023):1-15.PMID:37318704
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Anim Biotechnol (2023):1-12.PMID:36756956
- J Obstet Gynaecol Re PMID:39169658
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Balk Med J 41.6 (2024).PMID:39319820
- Vet Parasitol (2024):110284.PMID:39126893
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- J Obstet Gynaecol Re PMID:39169658
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Balk Med J 41.6 (2024):491.PMID:39319820
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Fitoterapia (2024):106245.PMID:39393711
- Cell J 25.8 (2023):554.PMID:37641417
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- World J Oncol (2024):.
- J Int Med Res 48.4 (2020).PMID:31891283
- Biochem Genet (2023):1-18.PMID:37148331
- Comb Chem High T Scr (2024).PMID:35894460
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Transl Cancer Res 13.4 (2024).PMID:38737693
- Transpl P 52.1 (2020):398-405.PMID:31928781
- Iran J Immunol (2023).PMID:37865874
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Heliyon (2024).
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- hLife (2024).
- Acs Omega (2024).
- Food Hydrocolloid 120 (2021):106980.
- J Clean Prod 315 (2021):128201.
- Indian J Pharm Sci 86.3 (2024).
- Acs Appl Mater Inter (2024).PMID:39167710
- Viruses 16.8 (2024):1239.
- Toxins 16.7 (2024):319.
- J Tradit Compl Med (2024).
- Small (2024):2402308.PMID:3911
- Rev Bras Farmacogn (2024):1-7.
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- J Pharm Anal (2024):101053.
- Appl Entomol Zool (2022):1-14.
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Nutrients 16.14 (2024):2346.
- Int J Mol Sci 25.15 (2024):8340.
- Nutrients 16.14 (2024):2314.
- HemaSphere 5.7 (2021).PMID:34136753
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- J Inflamm Res 14 (2021):2445.
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Bioorg Chem (2024):107731.
- Antioxidants 13.11 (2024) 1320.
- Front Oncol 10 (2020):387.
- Mol Ther Nucl Acids (2020).
- Mater Res Express 7.2 (2020):025401.
- scienceasia (2024).
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Heliyon (2024).
- Mater Express 10.1 (2020):102-111.
- Bioact Mater 44 (2025):220-235.
- Biosens Bioelectron (2024):116875.
- Carbohyd Polym (2024):122897.
- Drug Resist Update (2024):101161.
- Int J Mol Sci 25.20 (2024):11184.
- Antioxidants-Basel 13.11 (2024):1289.
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- bioRxiv (2024) 2024-10.
- Ecotox Environ Safe 286 (2024):117233.
- Gene (2024) 149056.
- Phytother Res 34.4 (2020):836-845.
- bioRxiv (2025):2025-01.
- New J Chem 48.11 (2024):5068-5073.
- Biomedicines 12.11 (2024):2543.
- Adv Funct Mater 29.50 (2019):1906690.
- Heliyon (2024).
- Faseb J 38.15 (2024):e23876.
- Front Pharmacol 15:1453938.
- Drug Des Dev Ther (2024):5841-5851.
- J Funct Foods 123 (2024):106621.
- J Hazard Mater (2024):136113.
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- J Integr Med-Jim (2024).
- Phytomedicine 86 (2021):153565.PMID:33945919
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Biomed Pharmacother 179 (2024):117370.
- J Transl Med 22.1 (2024) 1-16.
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Biomaterials 272 (2021):120757.PMID:33798960
- Acs Appl Nano Mater (2024).
- Front Bioeng Biotech 12 (2024):1460870.
- J Hazard Mater (2024) 135735.
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Front Pharmacol 15 (2024):1384141@0.jpg
- J Biol Chem 297.2 (2021).PMID:33722608
- Front Pharmacol 11 (2021):618262.PMID:33551818
- Fiber Polym (2022):1-9.
- Bioact Mater 43 (2025):32-47.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Int J Biol Sci 20.12 (2024):4713-4730.
- J Nutr Biochem (2024):109769.PMID:9276944
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- J Transl Med 22.1 (2024):1-16.
- Phytomedicine (2024):156091.
- Mol Ther-Nucl Acids (2020).
- Int J Mol Sci 25.19 (2024):10339.
- Int J Mol Sci 25.19 (2024):10496.
- Pharmaceuticals-Base 17.10 (2024):1295.
- Chem Eng J (2024):156542.
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Biomed Res Int 2021 (2021).PMID:34373837
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- Sensors & Diagnostics (2024).
- Phytomedicine (2024):155347.
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Mol Med 29.1 (2023):6.PMID:36647009
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Adv Funct Mater (2024):2305827.
- Int J Pept Res Ther 29.2 (2023):19.
- J Inflamm Res (2023):1045-1057.PMID:36936349
- Sensor Actuat B-Chem 381 (2023):133437.
- View-China 4.2 (2023):20220052.
- Adv Funct Mater (2023):2309690.
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Int J Gen Med (2023):5817-5839.PMID:38106976
- bioRxiv (2023):2023-05.PMID:37292976
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Pharmaceutics (2023) 15(12):2713.
- Int J Mol Sci 25.2 (2024):919.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Food Sci Nutr (2023).
- Front Immunol 15 (2024):1347683.PMID:38343537
- Kaohsiung J Med Sci (2024).PMID:38340032
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Cancers 14.21 (2022):5218.PMID:36358640
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Cells 11.22 (2022):3580.PMID:36429010
- Mol Cell Toxicol (2022):1-11.
- Aquaculture 564 (2023):739060.
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Mater Today Chem 27 (2023):101331.
- bioRxiv (2024):2024-02.
- Mater Today Bio (2024):100958.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Antioxidants Basel 13.3 (2024):264.
- Iscience 26.9 (2023).PMID:37670789
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Front Mar Sci 9 (2022):861117.
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Nanophotonics 11.22 (2022):5089-5100.
- Chem Eng J 474 (2023):145358.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Front Microbiol 14 (2023).PMID:37645224
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Biocell 47.8 (2023).
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Appl Entomol Zool 58.4 (2023):303-313.
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Crystals 13.7 (2023):1067.
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- bioRxiv (2022):2022-04.
- Biocell 47.8 (2023).
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Ceram Int 49.15 (2023):25953-25963.
- Ann Hematol (2023):1-12.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Oncol Lett 26.1 (2023):1-17.
- Crit Rev Eukar Gene 34 (2024).
- Adv Funct Mater (2023):2214998.
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Front Immunol 14 (2023).PMID:37901236
- Biochip J (2023):1-10.
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Mol Cell Toxicol (2023):1-10.
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- New J Chem (2024).
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Theranostics 14.7 (2024):2687.
- Pharmaceutics 16.6 (2024):744.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- Bio-Des Manuf 5.2 (2022):358-370.
- Phytochem Lett 47 (2022):174-179.
- Front Pharmacol 15 (2024):1389976.
- Heliyon (2024).
- Available at SSRN 4830418.
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Tissue Cell 76 (2022).PMID:35182988
- Phytomedicine (2024):155744.
- bioRxiv (2024):2024-05.
- Nano Today 43 (2022):101416.
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Nano Today 41 (2021):101326.
- Tissue Cell 74 (2022):101680.PMID:34808429
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Netw Model Anal Hlth 13.1 (2024):1-15.
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Int J Bioprinting (2024).
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- Am J Cancer Res (2024):2852-2867.
- Cells 10.9 (2021):2399.PMID:34572049
- Nano Res (2022):1-8.
- Phytochem Lett 46 (2021):79-89.
- Nat Commun 15.1 (2024):4969.PMID:38862489
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- PeerJ 9 (2021):e11482.PMID:34820154
- Chin Herb Med (2024).
- Acs Omega (2024).
- Talanta (2024):126381.
- Mol Cell Biochem (2024) 1-13.
- J Cancer 15.13 (2024):4244-4258.
- Phytomedicine (2024):155656.
- Front Oncol 12 (2022):851300.PMID:35392243
- Cancers 14.19 (2022):4645.PMID:36230568
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Mater Today Adv 15 (2022):100271.
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Phytomedicine 105 (2022):154330.PMID:35905566
- J Oncol 2022 (2022).PMID:35909906
- Dis Markers 2022 (2022).
- Exp Ther Med 27.5 (2024):1-16.
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Mater Design (2024):112812.
- Viruses 14.8 (2022):1783.PMID:36016405
- J Oncol 2022 (2022).PMID:36059813
- J Funct Foods 114 (2024):106076.
- Molecules 27.16 (2022):5337.PMID:36014573
- Front Immunol 15 (2024):1326137.
- Foods 11.11 (2022):1575.PMID:35681325
- Phytomedicine 103 (2022):154199.PMID:35679793
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- J Cancer 13.6 (2022):1808.PMID:35399733
- Pharmaceuticals-Base 17.4 (2024):515.
- Cells 13.9 (2024):728.
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Acs Pharmacol Transl (2024).
- Heliyon (2024).
- Acs Appl Opt Mater (2024).
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Redox Biol (2024):103143.
- Nanoscale (2024).
- J Agr Food Chem (2024).
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Clin Transl Disc 2.2 (2022):e49.
- Acta Trop 232 (2022):106519.PMID:35584779
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Int J Mol Sci 25.24 (2024):13439.
Cell Counting Kit-8 (CCK-8) allows convenient assays using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(
Cell Counting Kit-8 allows sensitive colorimetric assays for the determination of the number of viable cells in the proliferation and cytotoxicity assays. The detection sensitivity of CCK-8 is superior to that of other tetrazolium salts, including MTT, XTT, and MTS.
Figure 1: Working mechanisms of Cell Counting Kit-8 (CCK-8).
Cell Number Determination
1. Inoculate cell suspension (100 μL/well) in a 96-well plate. Pre-incubate the plate in a humidified incubator (e.g., at 37°C, 5% CO2).
2. Add 10 μL of the CCK8 solution to each well of the plate. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
3. Incubate the plate for 1 - 4 hours in the incubator.
4. Measure the absorbance at 450 nm using a microplate reader.
Cell Proliferation and Cytotoxicity Assay
1. Seed cells in a 96-well plate at a density of 103-104 cells/well in 100 μL of culture medium to be tested. Culture the cells in a CO2 incubator at 37°C for 24 hours.
2. Add various concentrations of substances to be tested to the plate.
3. Incubate the plate for an appropriate length of time (e.g., 6, 12, 24 or 48 hours) in the incubator.
4. Add 10 μL of CCK8 solution to each well of the plate using a repeating pipettor. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
5. Incubate the plate for 1 - 4 hours in the incubator.
6. Before reading the plate, it is important to mix gently on an orbital shaker for 1 minute to ensure homogeneous distribution of color.
7. Measure the absorbance at 450 nm using a microplate reader.
Data Analysis
There are several ways to do statistical analysis. You can choose to use O.D. values or cell numbers. We offer one of them.
Cell viability (%) = [(As-Ab) / (Ac-Ab)] × 100
Inhibition rate (%) = [(Ac-As) / (Ac-Ab)] × 100
As = absorbance of the experimental well (absorbance of cells, medium, CCK8 and wells of the test compound).
Ab = blank well absorbance (absorbance of wells containing medium and CCK8).
Ac = control well absorbance (absorbance of wells containing cells, medium and CCK8).
Making a standard curve
1. The cell counting plate counts the number of cells in the cell suspension.
2. Using the medium, the cell suspension is diluted to a concentration gradient, usually requiring 5-7 concentration gradients, several replicate wells per group. Then inoculate the cells. (Note the number of cells per well. If you are diluting the cell suspension in a tube, carefully mix the cells again before adding the wells to the plate. The volume of the cell suspension in each well should be the same.)
3. Incubate until the cells are adherent (usually 2-4 hours), then add 10 μl of CCK8 per 100 μl of medium. Incubation was continued for 1-4 hours, and the absorbance at 450 nm was measured with a microplate reader. Make a standard curve with the number of cells as the X-axis coordinate and the O.D. value as the Y-axis coordinate.
The number of cells of the sample to be tested can be determined based on the curve. A prerequisite for using this standard curve is that the culture conditions are the same.
Precautions
1. Make sure the drug and CCK8 are evenly distributed in the medium.
2. The more cells proliferate, the darker the color; the stronger the cytotoxicity, the lighter the color.
3. For adherent cells, at least 1000 cells per well (100 μl medium). For leukocytes, at least 2500 cells per well (100 μl medium) are required due to their low sensitivity. The recommended 96-well plate has a maximum cell count of 25,000 per well. If the test is performed using a 24-well or 6-well plate, calculate the corresponding number of cells per well and adjust the volume of CCK8 to 10% of the total liquid volume per well.
4. Since the CCK8 assay is based on dehydrogenase activity in living cells, conditions or chemicals that affect dehydrogenase activity may result in a difference between the actual number of viable cells and the number of viable cells measured using CCK8.
5. WST-8 may react with a reducing agent to form WST-8 formazan. If a reducing agent (such as some antioxidants) is used, it will interfere with the test. If more reducing agent is present in the system to be tested, it is necessary to remove it.
6. After 2 hours of incubation, the background O.D. value is typically 0.1-0.2 units.
7. Be careful not to introduce air bubbles into the holes as they will interfere with the O.D. value.
8. If you want to sterilize the CCK8 solution, use a 0.2 μm membrane filter solution.
9. The incubation time will vary depending on the type and amount of cells in the well. Generally, leukocytes are less colored and may require longer incubation times (up to 4 hours) or large numbers of cells (~105 cells/well).
10. If there is high turbidity in the cell suspension, measure and subtract the O.D value of the sample at 600 nm or higher.
11. CCK8 cannot be used for cell staining.
12. The phenol red in the medium does not affect the experimental results. The absorbance of phenol red can be eliminated by subtracting the absorbance of the background in the blank hole during calculation, so it will not affect the detection.
13. The toxicity of CCK8 is very low. After the CCK8 assay is completed, the same cells can be used for other cell proliferation assays, such as crystal violet assay, neutral red assay or DNA fluorescence assay. (Unless the cells are extremely rare, it is not recommended.)
14. This kit can be used in E. coli but not in yeast cells.
15. Before reading the plate, you can mix gently on the shaker.
16. We recommend inoculation of cells in wells near the center of the plate. The medium in the outermost circle of holes is easily evaporated and can be filled with PBS, water or medium.
17. If you don't have a 450 nm filter. You can also use filters with absorbance between 430 and 490 nm, and 450 nm filters for optimum sensitivity.
18. Measure the absorbance at 450 nm. If you need to make a dual wavelength measurement, the absorbance at 650 nm can be determined as the reference wavelength.
19. The presence of metal ions in the drug may affect the sensitivity of CCK8. Lead chloride, iron chloride, and copper sulfate at a final concentration of 1 mM inhibit 5%, 15%, and 90% of the color reaction, reducing sensitivity. If the final concentration is 10 mM, it will be 100% inhibited.
Applications |
1) Cell proliferation determinations-the GlpBio Cell Counting Kit-8 (CCK-8) is water soluble, stable in culture, and non-toxic.
2) Cell viability assays-metabolic activity and dye generation changes in proportion to altered viability. 3) Cytokine assays-measure cytokine-induced proliferation. Cells can be recovered and expanded at the end of the study if desired. 4) Cytotoxicity assays-Cells death from cytotoxic chemicals has no effects on color development, only living cells convert the reagent into a colorimetric indicator. The reagent itself has negligible toxicity, and is generally safe for cells. |
Shipping | Ship with blue ice. |
Storage Conditions | Stored at 4°C protecting from light, and is stable for up to 12 months. Stored at -20°C protecting from light, and is stable for up to 2 years. |
Usage | For research use only! Not for use on humans. |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
-
Related Biological Data
Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data
LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data
Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data
Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data
Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data
H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data
After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data
Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.
Average Rating: 5
(Based on Reviews and 420 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *